Communiqués EirGenix Inc.

Actions

6589

TW0006589005

Produits pharmaceutiques

Cours en clôture Taiwan S.E. 19/08/2026			Varia. 5j.	Varia. 1 janv.
49,85 ^TWD	+2,36%		-2,45%	-19,21%

14/08	EirGenix Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
13/07	Le partenaire d'EirGenix obtient le feu vert de l'EMA pour un nouveau flacon de son biosimilaire contre le cancer du sein	MT

Communiqués

15/08/22	EirGenix : will attend 2022 Cathay Biopharmaceutical Corporate Day Hosted by Cathay Securities.	PU
12/08/22	EirGenix : Explanation of mass media reporting.	PU
11/08/22	EirGenix : The Company’s Board of Directors Resolved to Issue Employee Stock Warrants.	PU
11/08/22	EirGenix : Announcement of Board approve the permission of managers for competitive actions.	PU
11/08/22	EirGenix : The Board of Directors Appointed the 3rd term Remuneration Committee Member.	PU
11/08/22	EirGenix : Announcement of the Construction Design and Consulting Fee for New Plant.	PU
11/08/22	EirGenix : Announcement of the Production Line Expansion and Production Equipment at Zhubei Facility. (Budget Increase)	PU
10/06/22	EirGenix : Announcement of the tenure expired of Remuneration Committee of 2nd Board of Directors.	PU
10/06/22	EirGenix : Announcement of the appointment of the 3rd term Audit Committee members.	PU
10/06/22	EirGenix : Announcement of AGM's approval of suspension of the non-competition restriction on the 5th directors or representatives of directors.	PU
10/06/22	EirGenix : Shareholders Elect Board of Directors; Board of Directors Unanimously Elect Dr. Lee-Cheng Liu as Chairman.	PU
10/06/22	EirGenix : Announcement of Election of Directors at 2022 Annual Shareholders’Meeting.	PU
10/06/22	EirGenix : Important resolutions of EirGenix's 2022 Annual Shareholders' Meeting.	PU
19/04/22	EirGenix : Announcement of the Board of Directors resolved to update the vesting conditions of employee restricted stock awards in 2022.	PU
18/04/22	EirGenix : Announcement of Completion of the Capital Reduction Registration due to the RSA Write-off	PU
29/03/22	EirGenix : Announcement for Replacement of Representative of Juristic Person as Director.	PU
22/03/22	EirGenix : To announce the acquisition of major assets. (Supplement of March 9, 2022 announcement)	PU
22/03/22	EirGenix : Announcement of the Board of Directors resolution of the convening of the 2022 Annual Shareholders' Meeting.	PU
22/03/22	EirGenix : Announcement of the Board of Directors resolution of the issuance of the private placement of securities.	PU
22/03/22	EirGenix : Announcement of the Board of Directors Resolution on the first issuance of new shares for employee restricted stock awards in 2022.	PU
22/03/22	EirGenix : Announcement of the Board of Directors approval of the cancellation of restricted shares to employee stock awards.	PU
22/03/22	EirGenix : The Board of Directors resolved not to distribute dividends.	PU
22/03/22	EirGenix : Accumulated losses in 2021 aggregated to one-half of the paid-in capital.	PU
09/03/22	EirGenix : To announce the acquisition of major assets.	PU
09/03/22	EirGenix : will attend the Investment Forum by Cathay Securities.	PU